Ocular surface squamous neoplasia(ossn)

17,908 views 59 slides Aug 21, 2015
Slide 1
Slide 1 of 59
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59

About This Presentation

OSSM


Slide Content

OCULAR SURFACE SQUAMOUS NEOPLASIA(OSSN)

INTRODUCTION The term Ocular Surface Squamous Neoplasia [OSSN ] presently refers to the entire spectrum of dysplastic, pre-invasive and malignant squamous lesions of the conjunctiva and cornea

We have suggested the use of the " umbrella“ term ocular surface epithelial dysplasia (OSED ) but now feel that ocular surface squamous neoplasia (OSSN ) is a better terminology. OCULAR SURFACE denotes involvement of the conjunctiva or cornea; SQUAMOUS excludes other epithelial cells such as basal cells and melanocytes and NEOPLASIA includes both dysplastic and carcinomatous lesions . Ocular Surface Squamous Neoplasia G raham a. lee, MBBS, and L awrence w. hirst , MD S urvey of ophthalmology volume 39, number 6. may- june 1995

The term Ocular Surface Squamous Neoplasia (OSSN) was coined by Lee and Hirst which has three grades :- I. BENIGN DYSPLASIA • Papilloma • Pseudoepitheliomatous hyperplasia • Benign hereditary intraepithelial dyskeratosis II. PREINVASIVE OSSN • Conjunctival /corneal carcinoma in situ III. INVASIVE OSSN • Squamous carcinoma • Mucoepidermoid carcinoma

EPIDEMIOLOGY T hird most common ocular tumour after melanoma and lymphoma Common in Caucasians Common in older age group(6-7 decade) Males are affected more commonly than females Earlier onset in areas in latitude 30 degree from equator, declines considerably with increase in latitude Pts with HIV and Xeroderma pigmentosum present earlier All young patients with OSSN should be screened for HIV.

ETIOLOGY LIMBAL TRANSITION ZONE/STEM CELL THEORY Stem cells in the limbal epithelial crypts are the likely originators of this disease, and may take on cancer stem cell properties.

Effects of solar ultraviolet radiation UVB radiation causes direct DNA damage by crosslinking adjacent bases to form cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4 PPs ) Specific CC/TT dimer transitions of the p53 tumour-suppressor gene have been observed in OSSN lesions 29% increase in incidence of SCC per unit increase in exposure to ambient solar ultraviolet radiation

Other eye diseases thought to be related to UV-B exposure also have a high association with OSSN . pterygium pingueculum climatic droplet keratopathy cataract corneal degeneration

Reactivation of latent HPV infection . UV radiation also reactivates latent viruses such as HPV 16 HPV's E7 protein keeps infected cells in a proliferative state while E6 inhibits cell cycle arrest of DNA-damaged cells.

Failure of DNA repair mechanisms An increased incidence of OSSN has been reported in conditions like Xeroderma Pigmentosa , where the DNA repair mechanism is defective

Immunosuppression UV radiation HIV and vitamin A deficiency weakens the tumour surveillance system and allows DNA damaged cells to proliferate into tumours . Vitamin A deficiency interferes with ocular surface integrity creating micro-abrasions through which HPV may invade the conjunctival basement membrane and epithelial cells.

Miscellaneous Chronic exposure keratopathy secondary to long standing facial nerve palsy may be associated with OSSN exposure to petroleum products heavy cigarette smoking chemicals such as trifluridine and arsenicals ocular surface injury Chronic inflammatory conditions- pemphigoid , atopic eczema, chronic blepharoconjunctivitis

Clinical Features Patients with OSSN may be asymptomatic or present with chronic redness and irritation of the eye . Visual acuity is not affected unless there is extensive corneal involvement OSSN may grow within weeks to years; in most cases, the history is of several months

The lesions are described as being slightly elevated , variably shaped, relatively sharply demarcated from the surrounding normal tissues, accompanied by feeder blood vessels and colored from pearly gray to reddish gray depending on the vascularity of the tumor They most commonly straddle the nasal or temporal limbus between the palpebral fissures

The following appearances may be seen.    a     Gelatinous mass with superficial vessels    b      White leukoplakic plaque that covers the lesion    c     Papillomatous lesion with corkscrew-like surface blood vessels   

In clinical practice, gelatinous type is the commonest . The gelatinous lesion can again be circumscribed , which are most common nodular variety , which has a propensity for rapid growth diffuse variety , the least common, which can masquerade as chronic conjunctivitis

The corneal side of the lesion may be seen as an opalesence of the epithelium, slightly raised in comparison to adjacent normal epithelium the edges of which are usually sharply defined . It is best appreciated by retroillumination . The lesion is usually nonpigmented though pigmented OSSN may also occur. OSSN may sometimes mimic a pterygium or a pinguecula . It has also been known to occur in a pre-existing pinguecula or pterygium .

It is nearly impossible to categorise OSSN as benign or malignant based on clinical appearance alone. Larger lesions that are fixated to the underlying tissue are usually malignant.

Staining with fluorescein sodium or Rose Bengal helps in the diagnosis by showing up the papillary or granular nature of the lesion and by delineating its extent Anterior segment OCT may be done to find out the extent of deep involvement as well as intraocular and angle invasion

Intraocular invasion is rare ,heralded by onset of iritis , glaucoma, scleral thinning or retinal detachment. Regional and systemic metastases are also uncommon. Common sites of metastasis include preauricular,submandibular and cervical lymph nodes, parotid gland, lungs , and bone.

DIFFERENTIAL DIAGNOSIS Pterygium papilloma pingueculum , nevus. Malignant melanoma pyogenic granuloma pseudo- epitheliomatous hyperplasia Corneal pannus from any cause Mooren's ulcer , fatty degeneration of the cornea and epithelial dystrophy of the cornea

Papilloma may occur anywhere on the conjunctiva, may be sessile or pedunculated , has a punctate vascular pattern, occurs in younger patients,but ultimately may only be difterentiated by histologic examination

Malignant melanoma has a regular smooth surface , lacks gelatinous or leukoplakic surface disturbances and may become ulcerated

Benign nevi tend to occur in the interpalpebral zone , from the limbus to the caruncle , to occur in younger patients, and to have distinctive cysts on slit-lamp examination

HISTOPATHOLOGY DYSPLASIA: Mild - less than a third thickness occupied by atypical cells Moderate - three quarters thickness occupied by atypical cells Severe -- nearly full thickness occupied by atypical cells CARCINOMA IN SITU : as above with loss of the normal surface layer INVASIVE SQUAMOUS CELL CARCINOMA : as above when the basement membrane of the basal epithelial layer has been breached and invasion of the substantia propria has occurred.

Spindle cell, Mucoepidermoid and Adenoid- Squamous are three aggressive variants

TREATMENT SURGICAL EXCISION

video

TOPICAL CHEMOTHERAPY Topical chemotherapy may be used preoperatively , intraoperatively or postoperatively . Its preoperative use is seen in cases with extensive lesions where it helps to reduce the tumor size and makes the tumor more amenable to surgical excision . Intraoperatively , chemotherapy may have a role in place of adjuvant cryotherapy postoperatively can be beneficial for managing cases with residual disease or positive surgical margins.

MITOMYCIN C Mitomycin C is the most commonly used topical chemotherapy agent It is a non cell cycle specific ALKYLATING AGENT that acts by alkylating the cross-linked DNA and inhibits DNA, RNA, and protein synthesis . MMC is used in concentrations of 0.04% qid , 4 days a week for 4 weeks. Overall , success rates ranging from 87 to 100% have been reported .

5-FU Is a pyrimidine analogue that acts by integrating with the DNA during S phase. It also interferes with RNA synthesis . It is used as 1% topical solution . Side effects are similar to MMC

INTERFERONS Interferons are protein molecules that bind to cell receptors and trigger synthesis of effector proteins that can inhibit viruses, activate immunocompetent cells , and regulate oncogenes . Reports are emerging on the use of topical IFN- 2b for OSSN. It is more expensive than MMC and 5 FU, requires prolonged treatment but has a better safety profile

RADIOTHERAPY Plaque brachytherapy using radiation sources like Strontium 90 or Rhuthenium 106 is useful as an adjuvant to support surgical excision. Complications include conjunctival scarring , symblepharon , dry eye, cataract, scleral and corneal ulceration .

SUMMARY [1] Suspected OSSN < 3 clock hours –Excision biopsy + base/ edge cryotherapy + alchoholepitheliectomy is done.

[2] Suspected OSSN 3 – 6 clock hours – As there is a risk of producing limbal stem cell deficiency, excision biopsy + cryotherapy is better avoided . A diagnostic biopsy is required In pre-invasive lesions topical chemotherapy is likely to achieve tumour resolution . If invasive, surgery + cryotherapy is done after chemoreduction with 4 to 6 cycles of topical chemotherapy.

[3] OSSN > 6 clock hours – A diagnostic biopsy is required. In pre-invasive lesions topical chemotherapy is quite likely to achieve tumour resolution . If invasive, surgery + cryotherapy is done after chemoreduction with 4 to 6 cycles of topical chemotherapy . If there is no response to chemotherapy palliative radiotherapy or extensive surgery like enucleation / exenteration may be required.
Tags